K-numberK240983
Device nameDiscovery Pico; Discovery Pico Plus; Discovery Pico Derm
ApplicantQuanta System Spa
Product codeGEX
Device classClass II
Decision dateJun 6, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Discovery Pico Family comprises three multi-wavelength laser systems (Discovery Pico, Discovery Pico Plus, and Discovery Pico Derm) intended for aesthetic, cosmetic, and surgical dermatology applications. These devices deliver laser energy at multiple wavelengths (1064 nm, 532 nm, 694 nm in Q-switched and picosecond modes, plus optional IPL and 2940 nm sources) to treat benign vascular lesions, pigmented lesions, tattoos, unwanted hair, acne scars, and wrinkles across various skin types.

Technological characteristics

The subject device offers the same laser wavelengths and modes as its predicate (Quanta K191842) but with updated pulse duration ranges in picosecond mode: 1064 nm PS from 450–800 ps (versus 450 ps in the predicate) and 532 nm PS from 370–600 ps (versus 400 ps). Maximum fluence values are comparable or slightly lower (e.g., 1064 nm PS: 5.6 J/cm² vs. predicate's 10 J/cm²). Handpiece options, repetition rates, and overall thermal delivery mechanisms remain substantially identical to the predicate device.

Test standards cited

IEC 60601-1:2005+AMD1:2012+AMD2:2020 (general medical electrical safety); IEC 60601-1-2:2014+AMD1:2020 (EMC); IEC 60601-2-22:2007+AMD1:2012 (laser equipment safety, including pulse duration accuracy per 2019 edition); IEC 60825-1:2014 (laser safety classification); IEC 62304:2006+AMD1:2015 (software lifecycle); ISO 10993-1:2009 (biocompatibility); ISO 17664-1:2021 (reprocessing/disinfection); IEC 60601-2-57:2011 (non-laser light source safety for IPL).

Substantial equivalence argument

The subject device uses identical laser technology, wavelengths, and treatment modes as predicate K191842, with no changes to indications for use. Minor differences in pulse width ranges (higher upper limit at 1064 nm PS and lower limit at 532 nm PS) and slightly lower maximum fluence values do not raise new safety or effectiveness concerns because clinically relevant thermal effects depend on maximum fluence rather than pulse energy alone. All non-clinical bench testing per updated standards met acceptance criteria, confirming safe and effective operation within the same clinical application profile as the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →